|
March 18, 2020
As the number of U.S. coronavirus cases continues to increase, we are writing to urge you to ensure Medicare patients have access to the care management and coordination provided by clinicians and healthcare teams engaged in value based care models such as accountable care organizations (ACOs) and value based models run by the Center for Medicare and Medicaid Innovation. Congress has long encouraged clinicians and healthcare organizations to adopt a value-based approach to patient care by participating in programs such as the Medicare Shared Savings Program (MSSP), advanced Alternative Payment Models (APMs) under the Medicare Access and CHIP Reauthorization Act, and others. Under the financial evaluation methodologies of many of these models, participants are directly responsible for the skyrocketing costs that we expect to accrue during the COVID-19 pandemic. This is causing significant concern and uncertainty amongst ACOs and APM participants, especially as key program deadlines swiftly approach, including spring application deadlines, summer participant agreement deadlines, and upcoming deadlines for risk-bearing APM entities to exit to avoid financial accountability for performance year 2020. To enable these front line clinicians and care teams to continue to focus on providing high quality, coordinated care to patients, we urge you to preclude the financial impact or shared loss repayment for all ACOs and other value based program participants based on costs accrued related to COVID-19 care and during this public health crisis. Thank you for your consideration of this important issue. Sincerely, American Academy of Family Physicians
|